Christopher D. Ozeroff
2018
In 2018, Christopher D. Ozeroff earned a total compensation of $310.3K as Secretary, Senior Vice President and General Counsel at ARCA biopharma, a 29% decrease compared to previous year.
Compensation breakdown
| Salary | $297,343 |
|---|---|
| Other | $12,914 |
| Total | $310,257 |
Ozeroff received $297.3K in salary, accounting for 96% of the total pay in 2018.
Ozeroff also received $12.9K in other compensation.
Rankings
In 2018, Christopher D. Ozeroff's compensation ranked 13,095th out of 14,244 executives tracked by ExecPay. In other words, Ozeroff earned more than 8.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,095 out of 14,244 | 8th |
Division Manufacturing | 5,307 out of 5,765 | 8th |
Major group Chemicals And Allied Products | 1,984 out of 2,128 | 7th |
Industry group Drugs | 1,702 out of 1,817 | 6th |
Industry In Vitro and In Vivo Diagnostic Substances | 63 out of 72 | 13th |
Source: SEC filing on October 25, 2019.
Ozeroff's colleagues
We found two more compensation records of executives who worked with Christopher D. Ozeroff at ARCA biopharma in 2018.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019